The 2025-2030 World Outlook for Prostate Cancer Treatments - Image 1

Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Prostate Cancer Treatments

Subjects

Out of stock

Price data checked 5 days ago

View at Amazon

One email. No newsletter. No nudges.

Sold out. We send one email the moment it's back. Last time, that took just a day or two.

Out of stock 5 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

This study covers the world outlook for prostate cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of prostate cancer treatments as including all commonly understood services falling within this broad category, such as digital rectal exam (DRE) and prostate specific antigen (PSA) test diagnostic techniques; radical prostatectomy, orchiectomy, transurethral resection (TUR) surgeries; 3D conformal, intensity modulated, stereotactic body, and proton beam external radiation therapies; permanent and temporary brachytherapy radiation therapies; and docetaxel, etoposide, vinblastine, carboplatin, and vinorelbine chemotherapy, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Bayer, GE, Ipsen, Johnson & Johnson, Pfizer, and Siemens. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CYDVL4MN
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 08 April 2024

The 2025-2030 World Outlook for Prostate Cancer Treatments

Sold out. We send one email the moment it's back. Last time, that took just a day or two.

Price History & Forecast

Price Distribution

Description

Product Specifications

Similar Products You Might Like

The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention

The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan

The 2013-2018 Outlook for Prostate Cancer Therapeutics in Africa

The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in India

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States

The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics for US Zip Codes

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China

Springer - Transforming Prostate Cancer Care in Africa Book

IntechOpen Prostate Cancer - Diagnostic and Therapeutic Advances

Prostate Cancer - From Bench to Bedside

Prostate Cancer - Original Scientific Reports and Case Studies

Prostate Cancer: Advancements in the Pathogenesis, Diagnosis and Personalized Therapy

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics for US Zip Codes

Management of Advanced and Metastatic Prostate Cancer, An Issue of Urologic Clinics of North America (Volume 53-2) (The Clinics: Surgery, Volume 53-2)

Novas tendências no tratamento do cancro da próstata: Multidisciplinaridade no tratamento do cancro da próstata

Prostate Cancer: Assessment and Treatment

Refining Localized Prostate Cancer Management: Concepts and Controversies, An Issue of Urologic Clinics of North America (Volume 53-1) (The Clinics: Surgery, Volume 53-1)